Adverse Drug Reactions: Building Drug Safety Beyond Marketing Authorisation
hr (code pays fourni par la source)
0 citations
Journal of Clinical Medicine
Andrej Belančić
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
181Publications signalées
887Citations signalées
1Affiliations récentes
Les institutions déclarées
Les domaines associés
Diabetes Treatment and ManagementNeurogenetic and Muscular Disorders ResearchBlood Pressure and Hypertension StudiesDiet and metabolism studiesHealth Systems, Economic Evaluations, Quality of Life
Les publications récentes
Interventional Treatment of Arterial Hypertension in The Modern Era: An Updated Review from the Young Investigator Group of the European Society of Hypertension
Yusuf Ziya Şener, Costantino Mancusi, Alexandr Ceasovschih, Andrej Belančić et autres
nl, it, ro, hr, gr, pt, be, cz, si, cy (code pays fourni par la source)
0 citations
High Blood Pressure & Cardiovascular Prevention
Contemporary Landscape of Active Clinical Trials in Pancreatic Ductal Adenocarcinoma: A ClinicalTrials.gov—Based Narrative Review with a Scoping Approach
Laura Radoš, Sara Matulić Matulić Čubranić, Marin Golčić, Iva Skočilić et autres
hr (code pays fourni par la source)
0 citations
Pharmaceuticals
Hypertension in obesity: A focus on individualized pharmacotherapy and the role of body composition, on behalf of the European Society of Hypertension Working Group on Diabetes and Metabolic Risk Factors and Working Group on Lifestyle, Cardiovascular Pharmacotherapy and Adherence
Christina Antza, Andrej Belančić, Jens Jordan, Alberto Esteban et autres
gr, hr, de, ca, us, es, gb, nl, at, be (code pays fourni par la source)
0 citations
British Journal of Clinical Pharmacology
Chronotherapy in Oncology: Aligning Cancer Treatment with Biological Time
Andrej Belančić, Marin Golčić, Almir Fajkić, Vlatka Bračić et autres
hr, ba (code pays fourni par la source)
0 citations
Journal of Personalized Medicine
Population-level trends in melanoma burden, stage at diagnosis, and indirect costs in Croatia: a descriptive analysis
Goran Benčina, Marija Buljan, Boris Benčina, Elvira Meni Maria Gkrinia et autres
hr, in (code pays fourni par la source)
0 citations
Expert Review of Pharmacoeconomics & Outcomes Research
From Needle to Pill: Oral PCSK9 Inhibition Enters the Lipid-Lowering Armamentarium
Andrej Belančić, Josip A. Borovac
hr (code pays fourni par la source)
0 citations
Journal of Cardiovascular Pharmacology and Therapeutics
Trends in glucagon-like peptide-1 receptor agonist utilization and expenditure in Croatia
Andrej Belančić, Marta Kučan Štiglić, Almir Fajkić, Ana Jelaković et autres
hr, ba (code pays fourni par la source)
0 citations
Journal of International Medical Research
The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma
Farideh Javid, Marin Golčić, Anja Harej Hrkać, Andrej Belančić
gb, hr (code pays fourni par la source)
0 citations
Pharmacology Research & Perspectives
Chronotherapy in Hematological Malignancies: Evaluating the Rationale and Evidence
Andrej Belančić, Marko Skelin, Yun Wah Lam, Almir Fajkić et autres
hr, cn, bd, hk, ba, it (code pays fourni par la source)
0 citations
Pharmacology Research & Perspectives
Preventive Strategies to Reduce Sarcopenia Risk During GLP-1-Based Anti-Obesity Therapy
Andrej Belančić, Kristina Skroče, Elvira Meni Maria Gkrinia, Mihaela Marinović Glavić et autres
hr, jp (code pays fourni par la source)
0 citations
Journal of Clinical Medicine
Glucagon-like Peptide-1 Receptor Agonists and Dual Incretin Therapies Across HFpEF and Cardiovascular Outcomes Trials in Patients with Obesity
Andrej Belančić, Sanja Klobučar Majanović, Kristina Skroče, Andreea Ciudin et autres
hr, es (code pays fourni par la source)
0 citations
Medicina
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.